Metabolomic Characterization of Inflammatory Bowel Diseases

Metabolomic approaches have transformed our understanding of inflammatory bowel diseases (IBD) by providing a comprehensive picture of the small molecules that reflect host physiology, microbial activity and environmental influences within the gut. By leveraging high-resolution mass spectrometry and nuclear magnetic resonance spectroscopy, researchers have delineated alterations in amino acids, short-chain fatty acids, bile acids, acylcarnitines and lipid mediators that distinguish Crohn’s disease and ulcerative colitis from healthy states, as well as active and remission phases. These metabolic signatures not only complement taxonomic and functional assessments of the gut microbiota but also yield candidate biomarkers for non-invasive diagnosis and prognostic stratification. Moreover, integration of metabolomic data with metagenomic and transcriptomic profiles has uncovered host–microbiome co-metabolisms, such as aminoacyl-tRNA synthetase pathways and dysregulated sulfur metabolism, which appear central to disease pathophysiology. The global significance of metabolomic characterisation extends to personalised therapeutic strategies, including tailored dietary interventions, microbiota-derived metabolite supplementation and real-time monitoring of treatment response.

Research from Nature Portfolio

Recent studies have advanced multi-cohort and longitudinal analyses to identify robust metabolite and microbial signatures in IBD. A cross-cohort integrative study analysed metagenomic and metabolomic data from diverse populations, revealing 36 consistently altered metabolites and novel commensal bacteria that underpin diagnostic biomarkers with high predictive accuracy. Integrative biological correlation maps highlighted deficiencies in microbial biotransformation and perturbations in aminoacyl-tRNA synthetase activity. A landmark longitudinal multi-omics investigation tracked host and microbial dynamics over one year, demonstrating shifts in metabolite pools—particularly acylcarnitines, bile acids and short-chain fatty acids—during disease flares and remission, and pinpointing functional dysbiosis markers central to pathogenesis. Complementary work on Crohn’s disease has elucidated a network of bacteria–metabolite interactions centred on sulfur metabolism, validated in gnotobiotic models, thereby offering mechanistic insight and enhancing predictive modelling of therapeutic outcomes.

Metabolomic Characterization of Inflammatory Bowel Diseases publication trend

The graph below shows the total number of articles in metabolomic characterization of inflammatory bowel diseases across all publications each year (not limited to Nature Index journals).

Technical terms

Metabolomics: Systematic analysis of small-molecule metabolites within cells, tissues or biofluids to reflect physiological and pathological states.

Short-chain fatty acids (SCFAs): Microbial fermentation products, such as acetate, propionate and butyrate, that influence gut immunity and epithelial function.

Multi-omics integration: Combined analysis of multiple omics datasets (for example genomics, metabolomics, proteomics) to reveal interconnected molecular pathways.

Biomarker: A measurable indicator of a biological condition or disease state used for diagnosis, prognosis or therapeutic monitoring.

Dysbiosis: Disruption of the normal microbial community structure and function, often linked to disease processes.

References

1. Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohorts. Nature Communications (2023).
2. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature (2019).
3. Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn’s disease and healthy individuals. Metabolomics (2014).
4. Novel, Objective, Multivariate Biomarkers Composed of Plasma Amino Acid Profiles for the Diagnosis and Assessment of Inflammatory Bowel Disease. PLOS ONE (2012).
5. Integrated microbiota and metabolite profiles link Crohn’s disease to sulfur metabolism. Nature Communications (2020).